Key Financial Data Of Group

Astellas Pharma Inc. - Filing #7595393

Concept 2022-04-01 to
2022-06-30
As at
2022-06-30
2021-04-01 to
2022-03-31
As at
2022-03-31
As at
2021-06-30
2021-04-01 to
2021-06-30
Key financial data of group
Business results of group
Cash and cash equivalents
313,013,000,000 JPY
315,986,000,000 JPY
301,920,000,000 JPY
Revenue
381,791,000,000 JPY
1,296,163,000,000 JPY
326,143,000,000 JPY
Profit (loss) before tax
31,679,000,000 JPY
156,886,000,000 JPY
35,830,000,000 JPY
Profit (loss), attributable to owners of parent
24,812,000,000 JPY
124,086,000,000 JPY
30,687,000,000 JPY
Comprehensive income, attributable to owners of parent
134,396,000,000 JPY
208,117,000,000 JPY
36,206,000,000 JPY
Equity attributable to owners of parent
1,539,052,000,000 JPY
1,460,308,000,000 JPY
1,382,869,000,000 JPY
Total assets
2,481,843,000,000 JPY
2,332,395,000,000 JPY
2,249,456,000,000 JPY
Basic earnings (loss) per share
13.59
67.08
16.56
Diluted earnings (loss) per share
13.59
67.05
16.55
Ratio of owners' equity to gross assets
0.620 xbrli:pure
0.626 xbrli:pure
0.615 xbrli:pure
Cash flows from (used in) operating activities
48,832,000,000 JPY
257,444,000,000 JPY
40,083,000,000 JPY
Cash flows from (used in) investing activities
-19,144,000,000 JPY
-62,413,000,000 JPY
-21,085,000,000 JPY
Cash flows from (used in) financing activities
-46,602,000,000 JPY
-216,298,000,000 JPY
-44,730,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.